You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
與騰訊(00700.HK)合作的醫療初創Medopad B輪融資籌得2,500萬美元
阿思達克 11-05 15:52

據《彭博通訊社》報道,與騰訊控股(00700.HK)合作的英國人工智能初創Medopad籌得2,500萬美元作臨床健康科技研究,而是次B輪融資是由Bayer領投。

Medopad位於英國,主要透過尋找及使用疾病的數碼標示以協助治療如阿茲海默症及糖尿病等,公司於去年與騰訊合作,開發可遙距監測柏金遜症患者的系統,而公司亦正努力在中國建立醫療人工智能實驗室。公司同時亦有與包括強生在內的企業合作,透過可穿載裝置監測病人情況並尋找最有效的治療方案。 ~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account